Four Decades for Justice
Led by two former Commissioners of the Federal Trade Commission—one of whom also served as U.S. Assistant Attorney General for Antitrust at the Department of Justice—Cravath’s highly regarded antitrust practice provides a wealth of experience and insight with respect to formulating global antitrust strategy, securing regulatory clearance for mergers and acquisitions, and defending against charges of anticompetitive behavior. Clients turn to Cravath to handle their most important antitrust work based on the Firm’s exceptional depth of knowledge and long track record of success in high‑stakes, complex and precedent‑setting matters, including U.S. v. IBM, U.S. v. AT&T and U.S. v. American Express.
We handle regulatory clearance for some of the world’s largest transactions, including in recent years advising on Anheuser‑Busch InBev’s $123 billion acquisition of SABMiller; British American Tobacco’s $97 billion merger with Reynolds American; Mylan’s $50 billion combination with Upjohn to form Viatris; and Afterpay’s $29 billion acquisition by Square. We regularly interface with competition agencies and recognize that advisory matters can present some of the most complicated and unusual antitrust issues for our clients. We work closely with clients to develop a deep understanding of their business, positioning us not only to provide the “answer,” but also to assist each client in finding the right and workable business solution.
Complex antitrust litigation is a hallmark of Cravath’s practice, and we bring to bear courtroom excellence and government experience to deliver the most comprehensive, innovative and tactical antitrust advice to our clients around the world—from initial investigation through final appeal. We handle antitrust litigation covering the entire spectrum, from managing class actions spread across the country to litigating individual actions in a single jurisdiction. We also excel at bet‑the‑company enforcement actions, trying and winning cases against the government. Trained as generalists, our litigators see the broader picture and are able to navigate the intersection between antitrust law and other areas, including securities and intellectual property, to devise creative and holistic solutions to our clients’ most pressing disputes.
In addition, we handle a variety of public and non‑public antitrust‑related governmental investigations in the United States and around the world, including investigations related to transactions and allegations of price fixing, coordination in output, monopolization and industry‑wide conspiracy.
Year after year, Cravath’s cross‑disciplinary team is recognized at the top of the nation’s most highly regarded antitrust practices. Chambers USA distinguishes our attorneys for handling “cutting‑edge matters at the forefront of antitrust,” and has repeatedly named Cravath its “Antitrust Law Firm of the Year.” We also have been named Benchmark Litigation’s “Antitrust Firm of the Year” and honored numerous times as “Regional Firm of the Year – Americas” by Global Competition Review (“GCR”) and “Competition Practice Group of the Year” by Law360. The Firm’s transactional and litigation matters are frequently recognized for their innovation and impact by Benchmark Litigation, GCR, and the Financial Times. In addition, we are consistently ranked as a top tier firm by leading industry publications including Benchmark Litigation, Chambers USA, GCR and The Legal 500 US.
Our team has earned repeated praise from clients, the market and the press, including:
We handle regulatory clearance for some of the world’s largest transactions, including in recent years advising on Anheuser‑Busch InBev’s $123 billion acquisition of SABMiller; British American Tobacco’s $97 billion merger with Reynolds American; Mylan’s $50 billion combination with Upjohn to form Viatris; and Afterpay’s $29 billion acquisition by Square. We regularly interface with competition agencies and recognize that advisory matters can present some of the most complicated and unusual antitrust issues for our clients. We work closely with clients to develop a deep understanding of their business, positioning us not only to provide the “answer,” but also to assist each client in finding the right and workable business solution.
Complex antitrust litigation is a hallmark of Cravath’s practice, and we bring to bear courtroom excellence and government experience to deliver the most comprehensive, innovative and tactical antitrust advice to our clients around the world—from initial investigation through final appeal. We handle antitrust litigation covering the entire spectrum, from managing class actions spread across the country to litigating individual actions in a single jurisdiction. We also excel at bet‑the‑company enforcement actions, trying and winning cases against the government. Trained as generalists, our litigators see the broader picture and are able to navigate the intersection between antitrust law and other areas, including securities and intellectual property, to devise creative and holistic solutions to our clients’ most pressing disputes.
In addition, we handle a variety of public and non‑public antitrust‑related governmental investigations in the United States and around the world, including investigations related to transactions and allegations of price fixing, coordination in output, monopolization and industry‑wide conspiracy.
Year after year, Cravath’s cross‑disciplinary team is recognized at the top of the nation’s most highly regarded antitrust practices. Chambers USA distinguishes our attorneys for handling “cutting‑edge matters at the forefront of antitrust,” and has repeatedly named Cravath its “Antitrust Law Firm of the Year.” We also have been named Benchmark Litigation’s “Antitrust Firm of the Year” and honored numerous times as “Regional Firm of the Year – Americas” by Global Competition Review (“GCR”) and “Competition Practice Group of the Year” by Law360. The Firm’s transactional and litigation matters are frequently recognized for their innovation and impact by Benchmark Litigation, GCR, and the Financial Times. In addition, we are consistently ranked as a top tier firm by leading industry publications including Benchmark Litigation, Chambers USA, GCR and The Legal 500 US.
Our team has earned repeated praise from clients, the market and the press, including:
Deals & Cases
September 19, 2023
On September 19, 2023, affiliates of private investment firm Lindsay Goldberg, in partnership with the company’s management, announced the completion of an investment in The Kleinfelder Group, a leading engineering, design, construction management, construction materials inspection and testing, and environmental professional services firm. Cravath is representing Lindsay Goldberg in connection with the transaction.
Deals & Cases
September 18, 2023
On September 18, 2023, OMERS Private Equity announced the signing of a definitive agreement to acquire a majority stake in Knight Commercial, a leading provider of commercial restoration services. Cravath is representing OMERS Private Equity in connection with the transaction.
Deals & Cases
September 12, 2023
On September 12, 2023, the Boards of WestRock and Smurfit Kappa announced the signing of a definitive transaction agreement to create Smurfit WestRock, a global leader in sustainable packaging. Together, Smurfit Kappa and WestRock generated combined last twelve months’ adjusted annual revenue of approximately $34 billion as of June 30, 2023. Cravath is representing WestRock in connection with the transaction.
Deals & Cases
September 11, 2023
Cravath represented Amgen, one of the world’s largest biopharmaceutical companies, in successfully defending against a Federal Trade Commission (“FTC”) challenge to Amgen’s pending $27.8 billion acquisition of Horizon Therapeutics (“Horizon”)—securing a consent order on September 1, 2023 that The Wall Street Journal described as “a rare instance” of the FTC “throwing in the towel on litigation.”
Deals & Cases
August 10, 2023
On August 10, 2023, Forward Air Corporation (“Forward”), a provider of transportation services, and Omni Logistics, LLC (“Omni”), a private logistics and supply chain management company that is majority owned by Ridgemont Equity Partners and EVE Partners, LLC, announced that they have entered into a definitive agreement under which Forward and Omni will combine in a cash-and-stock transaction, creating a combined company that generated approximately $3.7 billion of combined company adjusted revenue for the twelve months ended June 30, 2023. Cravath is representing Forward in connection with the transaction.
Activities & Publications
September 28, 2023
On September 26, 2023, Cravath partners Noah Joshua Phillips and Elad Roisman participated in the Roundtable on Policy Issues in Asset Management, which was co‑hosted by Harvard Law School and the Program on International Financial Systems in Washington, D.C.
Activities & Publications
September 21, 2023
On September 19, 2023, Cravath partner Noah Joshua Phillips participated in “Revising the Horizontal Merger Guidelines: The Path Forward,” a conference hosted by the American Enterprise Institute in Washington, D.C. The event convened leading economists and legal experts to discuss the Department of Justice and the Federal Trade Commission’s proposed revisions to the horizontal merger guidelines, the subsequent reaction among antitrust policymakers and practitioners and the likely path forward. Noah spoke on a panel entitled “Legal Implications,” which reviewed how the new guidelines could potentially affect merger reviews and, ultimately, jurisprudence.
Accolades
September 11, 2023
On September 8, 2023, Lawdragon announced the inclusion of 38 Cravath partners in its second edition list of the “500 Leading Litigators in America.” The list, assembled based on research and vetting by peers, recognizes the “array of talent in America’s great trial teams” who represent entities in cases spanning the areas of antitrust, finance, government investigations, intellectual property, M&A and securities, among many others.
Accolades
September 08, 2023
On September 8, 2023, The Am Law Litigation Daily featured a Cravath team, led by partners David R. Marriott, Timothy G. Cameron and Daniel K. Zach and of counsel Jesse M. Weiss, as “Litigators of the Week” for its successful defense of Amgen, one of the world’s largest biopharmaceutical companies, against a Federal Trade Commission (“FTC”) challenge to Amgen’s pending $27.8 billion acquisition of Horizon Therapeutics (“Horizon”)—securing a consent order on September 1, 2023 that ends all litigation and clears the path for the transaction to close.
Activities & Publications
August 29, 2023
On July 27, 2023, Cravath partner Lauren R. Kennedy was featured in Bloomberg Law’s “They’ve Got Next: 40 Under 40” series, which recognizes “the accomplishments of stellar young lawyers nationwide,” based on their client work, assumption of leadership roles, pro bono commitments and more. In a Q&A, Lauren described her work on a recent victory for client Blue Cross Blue Shield Association (“BCBS”) and member plans in a massive, multi‑district antitrust litigation, in the face of a prior adverse decision. Lauren explained her definition of success as earning a client’s trust and confidence through achieving great results, especially given the long timeline of much of the complex litigation she handles. She noted the influence on her legal career of Cravath partner Karin DeMasi, “by far [her] greatest mentor,” and emphasized the importance of a positive, can‑do attitude when interfacing with clients, aspiring to be “not an interloper who appears for a given litigation, but a true partner in their business and in achieving their big‑picture goals.”
Deals & Cases
September 19, 2023
On September 19, 2023, affiliates of private investment firm Lindsay Goldberg, in partnership with the company’s management, announced the completion of an investment in The Kleinfelder Group, a leading engineering, design, construction management, construction materials inspection and testing, and environmental professional services firm. Cravath is representing Lindsay Goldberg in connection with the transaction.
Deals & Cases
September 18, 2023
On September 18, 2023, OMERS Private Equity announced the signing of a definitive agreement to acquire a majority stake in Knight Commercial, a leading provider of commercial restoration services. Cravath is representing OMERS Private Equity in connection with the transaction.
Deals & Cases
September 12, 2023
On September 12, 2023, the Boards of WestRock and Smurfit Kappa announced the signing of a definitive transaction agreement to create Smurfit WestRock, a global leader in sustainable packaging. Together, Smurfit Kappa and WestRock generated combined last twelve months’ adjusted annual revenue of approximately $34 billion as of June 30, 2023. Cravath is representing WestRock in connection with the transaction.
Deals & Cases
September 11, 2023
Cravath represented Amgen, one of the world’s largest biopharmaceutical companies, in successfully defending against a Federal Trade Commission (“FTC”) challenge to Amgen’s pending $27.8 billion acquisition of Horizon Therapeutics (“Horizon”)—securing a consent order on September 1, 2023 that The Wall Street Journal described as “a rare instance” of the FTC “throwing in the towel on litigation.”
Deals & Cases
August 10, 2023
On August 10, 2023, Forward Air Corporation (“Forward”), a provider of transportation services, and Omni Logistics, LLC (“Omni”), a private logistics and supply chain management company that is majority owned by Ridgemont Equity Partners and EVE Partners, LLC, announced that they have entered into a definitive agreement under which Forward and Omni will combine in a cash-and-stock transaction, creating a combined company that generated approximately $3.7 billion of combined company adjusted revenue for the twelve months ended June 30, 2023. Cravath is representing Forward in connection with the transaction.
Activities & Publications
September 28, 2023
On September 26, 2023, Cravath partners Noah Joshua Phillips and Elad Roisman participated in the Roundtable on Policy Issues in Asset Management, which was co‑hosted by Harvard Law School and the Program on International Financial Systems in Washington, D.C.
Activities & Publications
September 21, 2023
On September 19, 2023, Cravath partner Noah Joshua Phillips participated in “Revising the Horizontal Merger Guidelines: The Path Forward,” a conference hosted by the American Enterprise Institute in Washington, D.C. The event convened leading economists and legal experts to discuss the Department of Justice and the Federal Trade Commission’s proposed revisions to the horizontal merger guidelines, the subsequent reaction among antitrust policymakers and practitioners and the likely path forward. Noah spoke on a panel entitled “Legal Implications,” which reviewed how the new guidelines could potentially affect merger reviews and, ultimately, jurisprudence.
Accolades
September 11, 2023
On September 8, 2023, Lawdragon announced the inclusion of 38 Cravath partners in its second edition list of the “500 Leading Litigators in America.” The list, assembled based on research and vetting by peers, recognizes the “array of talent in America’s great trial teams” who represent entities in cases spanning the areas of antitrust, finance, government investigations, intellectual property, M&A and securities, among many others.
Accolades
September 08, 2023
On September 8, 2023, The Am Law Litigation Daily featured a Cravath team, led by partners David R. Marriott, Timothy G. Cameron and Daniel K. Zach and of counsel Jesse M. Weiss, as “Litigators of the Week” for its successful defense of Amgen, one of the world’s largest biopharmaceutical companies, against a Federal Trade Commission (“FTC”) challenge to Amgen’s pending $27.8 billion acquisition of Horizon Therapeutics (“Horizon”)—securing a consent order on September 1, 2023 that ends all litigation and clears the path for the transaction to close.
Activities & Publications
August 29, 2023
On July 27, 2023, Cravath partner Lauren R. Kennedy was featured in Bloomberg Law’s “They’ve Got Next: 40 Under 40” series, which recognizes “the accomplishments of stellar young lawyers nationwide,” based on their client work, assumption of leadership roles, pro bono commitments and more. In a Q&A, Lauren described her work on a recent victory for client Blue Cross Blue Shield Association (“BCBS”) and member plans in a massive, multi‑district antitrust litigation, in the face of a prior adverse decision. Lauren explained her definition of success as earning a client’s trust and confidence through achieving great results, especially given the long timeline of much of the complex litigation she handles. She noted the influence on her legal career of Cravath partner Karin DeMasi, “by far [her] greatest mentor,” and emphasized the importance of a positive, can‑do attitude when interfacing with clients, aspiring to be “not an interloper who appears for a given litigation, but a true partner in their business and in achieving their big‑picture goals.”
Explore
Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.
Attorney Advertising. © 2023 Cravath, Swaine & Moore LLP.